Nordic Issuing

Ongoing case

CS Medica A/S

Back to all cases

CS Medica A/S

18 Aug - 1 Sep 2022Warrant exercise

CS Medica explore the potential of cannabinoids in the development of medical devices in order to answer the needs of patients who suffer from pain, autoimmune conditions, or symptoms related to disturbed homeostasis. On top of that, the company develop cosmetics with cannabis attributes.

Read more on CS Medicas webbsite

The offer in summary

Exercise period: 18 Aug - 1 Sep 2022

Price per share: DKK 9.30

Trading with warrants: Until 30 Aug 2022

Emission volume: Maximum of 1 160 800 warrants of series TO 1

Payment day: 1 Sep 2022

Marketplace: Spotlight Stock Market

Financial advisor: Sedermera Corporate Finance


Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.